Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.

Author(s): Grunze H, Marcuse A, Scharer LO, Born C, Walden J

Affiliation(s): Department of Psychiatry, LMU Munich, Munich, Germany. grunze@psy.med.uni-muenchen.de

Publication date & source: 2002, Neuropsychobiology., 46 Suppl 1:31-5.

Publication type: Clinical Trial; Randomized Controlled Trial

Although atypical antipsychotics are on the rise, traditional treatment of psychotic (or delusional) depression mostly includes the addition of classical antipsychotics to antidepressants. As there are only few data supporting this approach compared with antidepressant monotherapy, and almost no data comparing it with antidepressants of the latest generation, we conducted a retrospective chart analysis and a prospective, randomized open study on the efficacy and tolerability of nefazodone monotherapy versus combined treatment with amitriptyline and haloperidol in psychotic depression. The results suggest that the addition of classical antipsychotics should be reserved for those with very severe psychotic symptoms, but may not be needed in milder forms. Copyright 2003 S. Karger AG, Basel